Recently, there have been high levels of CD24 observed in mouse xenografts derived from both CD44+/CD24-/low and CD44+/CD24hi breast cancer cells suggesting important role for CD24 in tumour growth, whilst CD44+/CD24-/low breast cancer cells were not associated with increased tumourigenicity [26]. The gene discussed is CD44; the disease is neoplasm.